New hires:
Bayer named Samantha Avivi as chief marketing officer for its consumer health division in North America.
Elizabeth Thompson left Amgen to helm research and development at neuroscience drugmaker Acadia Pharmaceuticals.
Verily hired Bharat Rajagopal as chief revenue officer.
Stevanato Group tapped Ugo Gay as chief operating officer.
Daphne Zohar, the founding CEO of the biotech startup foundry PureTech Health, will helm Seaport Therapeutics.
Dr. Riann Egusquiza joined The CMT Research Foundation as director of research.
Define Ventures hired Evolent Health CEO Frank Williams as a venture partner.
PatientPoint hired former Humana and Walmart Health executive Sean Slovenski as its president.
BrightFocus Foundation named Jon Walsh as SVP of finance and administration.
Clinical trial platform Power added Murray Abramson, MD as chief medical officer.
BYG4lab named Tim Bickley as VP of U.S. sales.
Clinical research organization MMS hired James Zee as director of global statistical programming.
Verato named Andy Dé as chief marketing officer.
John Witkowski was named as president and CEO of Solesis, effective immediately.
IO Biotech named Faiçal Miyara, PhD as chief business officer.
TELA Bio named Howard N. Langstein, MD, FACS as VP of medical affairs.
Wheelhouse DMG hired Laura Chase as senior martech strategist.
Clinical-stage biopharma Xencor named Bart Cornelissen as SVP and CFO.
Veranova added Scott Lassonde as SVP and CFO.
Executive elevations:
Mike Ryan, executive director of the World Health Organization’s health emergencies program, was promoted to deputy director-general.
Board appointments:
PanTher Therapeutics appointed John Edwards as executive chair of the board of directors.
Theratechnologies named Elina Tea to its board of directors.
Qnovia added four members to its scientific advisory board.
Avalo Therapeutics added a number of biotech leaders to its board of directors.
OMass Therapeutics expanded its scientific advisory board with the appointment of Sarah Teichmann.
Departures:
Nick Shipley, the chief advocacy officer at the Biotechnology Innovation Organization, left the organization.
Jude Samulski stepped down as chief scientist of AskBio.
Banner Health CEO Peter Fine announced he will retire after 24 years at the health system.
